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OBJECTIVE: The aim of this study was to measure dynamic lung hyperinflation and its influence on dyspnea
perception in moderate and severe chronic obstructive pulmonary disease patients after performing activities of
daily living.
METHODS: We measured inspiratory capacity, sensation of dyspnea, peripheral oxygen saturation, heart rate and
respiratory rate in 19 chronic obstructive pulmonary disease patients. These measurements were taken at rest and
after performing activities of daily living (e.g., going up and down a set of stairs, going up and down a ramp and
sweeping and mopping a room).
RESULT: The inspiratory capacity of patients at rest was significantly decreased compared to the capacity of patients
after performing activities. The change in inspiratory capacity was -0.67 L after going up and down a ramp, -0.46 L
after sweeping and mopping a room, and -0.55 L after climbing up and down a set of stairs. Dyspnea perception
increased significantly between rest, sweeping and mopping, and going up and down a set of stairs. Dyspnea
perception correlated positively with inspiratory capacity variation (r = 0.85) and respiratory rate (r = 0.37) and
negatively with peripheral oxygen saturation (r = -0.28).
CONCLUSION: Chronic obstructive pulmonary disease patients exhibited reductions in inspiratory capacity and
increases in dyspnea perception during commonly performed activities of daily living, which may limit physical
performance in these patients.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major
cause of morbidity and mortality worldwide. In COPD
patients, structural changes occur in the lung parenchyma,
including remodeling, airway obstruction, destruction of the
alveolar septa and cellular communication, increases in air
space volume distal to the terminal bronchioles, and
decreases in pulmonary elastic recoil. These changes
interfere with the structures that allow airways to remain
open during expiration (1-3). These disease-related changes
cause air trapping and difficulty in air removal, leading to
airflow limitation and pulmonary hyperinflation, which
increases functional residual capacity/total lung capacity
and residual volume/total lung capacity ratios (4,5).
Dyspnea is the main symptom in COPD patients and the
first motivation for individuals to seek medical help. As the
disease progresses, the intensity of dyspnea increases and
leads to an anxiety state and a deterioration in quality of life.
Many COPD patients experience dyspnea even during
activities of daily living, such as walking and dressing.
There are several mechanisms responsible for dyspnea
during exercise in COPD. Among them, the most significant
includes the ineffectiveness of respiratory muscle function,
which leads to increased ventilation requirements and
dynamic pulmonary hyperinflation (1,3,6). It is well known
that increased ventilatory demand results in dynamic lung
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hyperinflation, thus increasing the sensation of dyspnea
during exercise and significantly contributing to reductions
in physical performance (4). Dynamic hyperinflation occurs
in COPD patients and can be measured by a simple method
that does not require sophisticated equipment and that
should be part of routine evaluations of COPD patients.
It is well described that dynamic pulmonary hyperinfla-
tion occurs in COPD patients during incremental exercise
tests (5,7). It has also been shown that COPD patients
develop lung hyperinflation during simple activities, such
as lifting pots and storing them in overhead bins (8).
However, whether this phenomenon occurs during the
activities of daily living that COPD patients can currently
accomplish has not yet been addressed. We hypothesize that
some specific activities of daily living induce dynamic
pulmonary hyperinflation in COPD patients. Thus, the
objective of this study was to measure dynamic pulmonary
hyperinflation and its influence on the sensation of dyspnea
in COPD patients with moderate to very severe airway
obstruction during the performance of activities of daily
living.
MATERIALS AND METHODS
This was a cross-sectional study that evaluated moderate
to very severe COPD patients according to GOLD 2010 (9).
The study was approved by the Ethics Committee of
UNIFESP (CEP No. 0353/03). We included 19 COPD
patients (13 males) with moderate to very severe degrees
of airway obstruction, with a mean post-bronchodilator
forced expiratory volume in the first second (FEV1) of
48.7¡7.1% predicted and a mean age of 64.1¡5.3 years.
Demographic and pulmonary function data are displayed in
Table 1.
The inclusion criteria were: COPD patients diagnosed
with moderate to very severe airway obstruction according
to the GOLD classification (9) and clinical stability with no
clinical exacerbation during the 30 days prior to the
beginning of the study. Furthermore, all participants were
required to sign an informed consent form. The exclusion
criteria were: inability to perform the slow vital capacity
maneuver, excessive perceived dyspnea during the test,
arterial oxyhemoglobin saturation (SpO2)#80% (7) during
activities and/or the need for oxygen supplementation. All
recruited patients participated in the study, and no
dropouts occurred.
Protocol
All COPD patients enrolled in the study were part of the
cardiopulmonary rehabilitation program of the Sa˜o Paulo
Adventist University Center Policlinic. All COPD patients
were taught in a simple manner to perform the proposed
activities of daily living (namely, walking up and down two
sets of stairs for one minute, walking twice up and down a
ramp 40 m in length with an 11% incline and sweeping and
mopping in two rooms that were 12 m2 each).
Heart rate (HR) was monitored with PolarH heart rate
monitors (model FS1, Sao Paulo, Brazil), respiratory
frequency (f) was measured by observing the elevation
and depression of the chest for a period of 60 seconds, and
blood pressure was monitored with the patients in the
sitting position with an aneroid sphygmomanometer
(Glicomed Anero´ide PremiumH, Sa˜o Paulo, Brazil) and a
stethoscope (Littmann Classic IIH, Sa˜o Paulo, Brazil) placed
directly over the brachial artery, thereby allowing the
examiner to hear the Korotkoff sounds as the cuff deflated.
SpO2 was monitored using a Nonin OnyxH pulse oximeter
(model Onyx 9500, Minnesota, USA) placed on the finger of
the patient, and the Borg scale (10) was used to verify
dyspnea and fatigue in the patients’ legs (0 represented the
slightest sensation of dyspnea and fatigue, and 10 repre-
sented the maximum sensation). Patients were first taught
about the Borg scale, and they were then asked to
enumerate their dyspnea and lower-limb fatigue scores
during the study.
Spirometry was performed using an EASY ONEH
spirometer (model frontline, Boston, USA) in the forced
(FVC) and slow (SVC) vital capacity modalities. After
calibration of the equipment, data such as name, age, sex,
race, weight, height, smoking habits, and diagnosis of
asthma were recorded. Spirometry was accomplished
according to the ATS criteria (11). The forced vital capacity
(FVC) modality was used to obtain the diagnosis and the
severity of disease for each patient. With the patient in the
sitting position, he/she was asked to place the mouthpiece
inside his/her mouth and to put on a nose clip to prevent
any air outflow leakage. Through a verbal stimulus, each
patient was asked to inhale deeply to his/her limit and then
to make a maximum expiration as quickly as possible. The
slow vital capacity (SVC) modality was used to obtain the
inspiratory capacity (IC). For this measurement, patients
were first asked to breathe normally into the mouthpiece;
then, when requested, a maximal inspiration followed by a
slow maximal expiration was performed.
The activities of daily living (walking up and down two
sets of stairs for one minute, walking twice up and down a
ramp 40 m in length with an incline of 11% and sweeping
and mopping two rooms that each had an area of 12 m2)
were performed in a random sequence. COPD patients were
instructed not to use any bronchodilators before performing
the activities (four hours for short-term medications and
12 hours for long-term medications).
Table 1 - Anthropometric, pulmonary function,
hemodynamic and respiratory baseline characteristics of
the COPD patients in this study.
Variables Pre-bronchodilator Post-bronchodilator
Age (years) 64.1¡5.3 -
BMI (kg/m2) 28.0¡3.0 -
BDI 8.0¡2.0 -
BODE 2.0¡1.0 -
Smoking history (pack-
years)
37.7¡13.1 -
FEV1 (%) 46.4¡9.1 48.7¡7.1
FVC (%) 71.2¡13.0 81.4¡11.2
FEV1/FVC (%) 65.5¡8.2 62.3¡6.8
IC (L) 2.4¡ 0.1 2.5¡0.1
IC (%) 70.8¡1.6 72.8¡1.3
Heart rate (bpm) 88.1¡10.3 -
Blood pressure (mmHg) 125.8¡13.5 -
Respiratory rate (rpm) 27.6¡3.9 -
SpO2 (%) 93.1¡4.2 -
Data are presented as the means¡standard deviations.
BMI =Body mass index; BDI =Baseline dyspnea index; BODE=Body mass
index, airway obstruction, dyspnea and exercise index; FEV1 = Forced
expiratory volume in 1 second; FVC= Forced vital capacity, FEV1/
FVC= forced expiratory volume in 1 second/forced vital capacity ratio;
IC = Inspiratory capacity; SpO2=arterial oxyhemoglobin saturation.
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At the end of each activity and with the patient seated,
heart rate, respiratory rate, blood pressure, and oxyhemo-
globin saturation were measured. Additionally, patients
were asked to score the sensations of dyspnea and fatigue in
their lower limbs according to the Borg scale; afterward, a
slow vital capacity maneuver was performed to obtain their
inspiratory capacities. The activities could either be per-
formed on the same day or on a different day. If performed
on the same day, an interval period between each activity
was set as at least 40 minutes or until the HR, f, IC, dyspnea,
and fatigue parameters had returned to baseline values.
For the IC measurements, each patient used a nasal clip
and breathed through a mouthpiece connected to the circuit
of the KoKoH equipment (Koko Spirometer, PDS Instru-
mentation, Lousville, Kentucky, USA), which numerically
and graphically recorded tidal volume values. When
stability of the end-expiratory volume was reached, the
patient was asked to inspire up to his/her total pulmonary
capacity. A minimum of three maneuvers up to a maximum
of eight were performed; to be considered reproducible, two
curves could not present a variation greater than 5% or
0.15 L (12,13). Inspiratory capacity was registered as the
value measured between the line of the end-expiratory
volume and total pulmonary capacity. The higher value of
two reproducible curves was considered for analysis.
Measurement of inspiratory capacity was performed within
two minutes after spirometry using the slow vital capacity
maneuver.
Pulmonary hyperinflation was considered when, after the
spirometry, a reduction in inspiratory capacity of 10% and/
or 0.15 L compared to the basal value was observed (14).
Up and down stairs (UDS)
COPD patients were instructed to walk up and down two
sets of stairs totaling 20 steps (each step was 0.18 m high and
0.33 m deep) at a comfortable speed over a period of one
minute. This time was chosen because we believe that this is
the time required for a healthy individual to perform this
activity in his/her day-to-day life. If they wished, they could
stop climbing the stairs; however, the timer was not stopped.
When the patient decided to continue with the activity until
the end of the test period, the time at which the patient
stopped and returned to complete the activity was noted.
Up and down a ramp (UDR)
The patient was instructed to go up and down a ramp
40 m in length with an average slope of 11% twice at a
comfortable pace (totaling 160 m in ascent and descent). The
baseline time for task completion was not pre-determined.
Sweeping and mopping in two rooms with areas of
12 m2 each (SM)
Prior to this activity, we spread an equivalent of 0.5 kg of
wet sand in each room. The patient was asked to sweep the
room floors with a broom and then mop them with a wet
cloth in a squeegee. The activity was terminated when the
patient perceived that the rooms were clean. We recom-
mended that the activity should be performed at a
comfortable pace.
During each activity, each patient was accompanied by
one investigator who asked him/her how he/she felt and if
he/she was able to continue testing. The patient was
informed that he/she could stop the test at any time.
The activities could be performed either on the same day
or on a different day; it was stipulated that either an interval
of 40 minutes of rest or enough time for the IC values,
dyspnea and fatigue to return to baseline should pass before
activities recommenced. The time interval between activities
was chosen according to previous publications from our
group (15,16).
Statistical analysis
The data are expressed as the means and standard
deviations. To analyze the normality of the data, we used
the Kolmogorov-Smirnov test. We used analysis of variance
with repeated measurements (ANOVA with the Bonferroni
post hoc test) to analyze IC, dyspnea, fatigue and SpO2 in
the three different activities (walking up and down the
ramp, sweeping and mopping and walking up and down
the stairs). Pearson’s correlation test was used to establish
correlations between IC variability and dyspnea. We
considered p,0.05 to be statistically significant. The sample
size was calculated based on the outcome variable (IC) from
the equation, namely the expected effect/standard devia-
tion (E/S) ratio. In this study, the IC expected effect chosen
was 0.15 L (minimal clinical difference to diagnose pul-
monary hyperinflation), and the sample standard deviation
considered was the IC variability after performance of the
activities (e.g., 0.15 L). Therefore, for an a= 0.05 and a
statistical power of b= 0.2, seventeen COPD patients
were needed to achieve outcomes significance.
RESULTS
There was a significant reduction in IC after the
performance of activities compared to resting IC values
(p= 0.04). The changes in IC were 0.67¡0.15 L/- 19.1¡1.0 %
(p= 0.003) after walking up and down the ramp,
-0.46¡0.15 L/- 13.1¡0.9 % (p= 0.05) after sweeping and
mopping and -0.55¡0.14 L/-15.7¡1.1 (p= 0.002) after walk-
ing up and down the stairs. Six, one, and six COPD patients
had the greatest degree of pulmonary hyperinflation after
walking up and down the ramp, mopping and walking up
Figure 1 - Boxplot of resting and post-activity (walking up and
down a ramp, sweeping/mopping and walking up and down
stairs) inspiratory capacities in COPD patients. Data are presented
as medians¡maximum/minimum values.
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and down the stairs, respectively. Six patients showed no
loss of IC greater than 0.15 L (Figure 1).
Dyspnea perception correlated positively with the varia-
tion in inspiratory capacity (r = 0.85, p= 0.0001) (Figure 2)
and respiratory rate (r = 0.37, p= 0.04) and negatively with
peripheral oxygen saturation (r = -0.28, p= 0.04). On average,
the value of perceived dyspnea increased two-fold after the
patients had walked to the end of the ramp, swept and
mopped the floors and completed the UDS test compared to
the resting values (p= 0.0036) (Figure 3). Likewise, the
average value of lower-limb fatigue perception in the COPD
patients increased more than two-fold for the same activities
between when they commenced and ended (p,0.005)
(Figure 4).
SpO2 values at rest and after each activity revealed no
significant decreases in any patient, and there was no
difference in SpO2 between the resting and post-activity
states (p= 0.65) (Figure 5). Likewise, blood pressure, heart
and respiratory rates were not significantly increased
between the resting and post-activity periods (p= 0.33,
p= 0.51 and p= 0.27, respectively).
DISCUSSION
The importance of this study resides in the fact that it
investigated the dynamic pulmonary hyperinflation result-
ing from activities of daily living in COPD patients. The
novel finding is that activities that were never tested before
(however commonly performed by COPD patients) were
shown to induce dynamic pulmonary hyperinflation. There
are several studies in the literature comparing the increases
in metabolic demand for activities with a high energy cost,
such as the 6-minute walking test (60 to 80% of oxygen
consumption) (10) and the endurance test (90% of oxygen
consumption) (13), and activities with decreased metabolic
demand, such as upper-limb exercises (e.g., the propriocep-
tive neuromuscular facilitation [PNF] technique) (16) and
activities of daily living (e.g., erasing black boards, lifting
pots and replacing lamps) (17). Nevertheless, when compar-
ing these studies to our data, either the methods of activity
assessment (e.g., accelerometer) (18) or the activities
themselves (19) were different. We believe that this is an
extremely important issue to be studied, as there are several
Figure 2 - Scatterplot of the association between the sensation of
dyspnea and delta (post-pre) inspiratory capacity. Data are
presented as individual inspiratory capacity values.
Figure 3 - Boxplot of resting and post-activity (walking up and
down ramp, sweeping/mopping and up and down stairs)
sensations of dyspnea in COPD patients. Data are presented as
medians¡maximum/minimum values.
Figure 4 - Boxplot of resting and post-activity (walking up and
down a ramp, sweeping/mopping and walking up and down
stairs) lower-limb fatigue levels in COPD patients. Data are
presented as medians¡maximum/minimum values.
Figure 5 - Boxplot of resting and post-activity (walking up and
down a ramp, sweeping/mopping and walking up and down
stairs) arterial oxyhemoglobin saturations in COPD patients. Data
are presented as medians¡maximum/minimum values.
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activities (over 30) that our patients perform in their day-to-
day lives that did not predispose the patients to any
deleterious effects that we are aware of.
For more than 30 years, IC has been measured to determine
lung volume at end-expiration, usually after performing a
physical activity. Researchers use it with a high level of
confidence by assuming that the total lung capacity does not
change from rest to peak exercise and stating that any IC
reduction is associated with the increase in functional residual
capacity (FRC) (4). The slow vital capacity (SVC) is a
reproducible maneuver both at rest and at peak exercise (14).
It has also been demonstrated to be a reliable maneuver that
provides accurate data, such as the decrease in inspiratory
reserve volume, which is associated with increases in FRC (14).
Additionally, measuring IC is a low-cost, noninvasive method.
Dynamic pulmonary hyperinflation is one factor that
contributes to the reduction of the physical capacity of
patients and correlates positively with oxygen consumption
at peak exercise (peak VO2) (4). It is already known that a
small lung capacity or ventilatory reserve can lower the
blood oxygen supply, thereby reducing the aerobic capacity
of the patient (4).
We analyzed IC behavior after each of the activities
performed in this study. We believe that most of the
pulmonary hyperinflation occurred in patients after walk-
ing up and down the ramp and the stairs. This was due to a
higher demand for physical effort and the use of larger
muscle groups than those required in the sweeping and
mopping activity. In their study, O’Donnell et al. (20)
identified a strong correlation between IC and the distance
walked during the 6-minute walking test. The same authors
argued that the reduction of IC leads to an increase in
ventilation required by the large muscle groups recruited in
a symptom-limit cycle ergometer test. In our study, we did
not measure minute ventilation and oxygen consumption;
however, the activities performed by our patients also
involved large muscle groups, and it is possible that they
required increased energy and oxygen consumption. This
was confirmed by the increased respiratory rate and
maximum oxygen consumption. This suggests that the
dynamic pulmonary hyperinflation that took place in these
activities occurred for the same reason. Many authors have
demonstrated the association of increased pulmonary
ventilation and the development of dynamic pulmonary
hyperinflation during upper-limb exercises (10,14,20) in
COPD patients.
Despite the fact that the sweeping and mopping activities
are not considered as intense as the other activities
mentioned above, they also resulted in a significant IC
reduction. Most of the muscles required for the completion
of this activity are located in the upper limbs, which are
typically composed of muscle groups with less muscle mass
and lower maximal oxygen consumption compared to the
lower-limb muscles. This proportionality has been demon-
strated by Celli et al. (21), who showed that, after exercise
with a cycle ergometer, oxygen consumption was lower in
the upper limbs (9.3¡1.1 ml/kg) than in the lower limbs
(30.8¡ 3.2 ml/kg). However, both the range of motion and
the degree of freedom of the shoulder girdle joint are
significantly larger than those of the lower limbs. This
allows the arms to perform movements that depart from the
midline of the body. Therefore, proportionally, the force and
torque required for the execution of each arm move-
ment increases significantly, resulting in greater oxygen
consumption (22). Porto et al. (15) were the first to
demonstrate the development of dynamic lung hyperinfla-
tion in COPD patients during exercises with diagonal
movements (PNF technique) that resemble the activities of
daily living that involve the arms. The authors also showed
that the proportion of IC reduction in the upper-limb
exercises was greater than in the lower limbs in patients
with COPD for the same metabolic demand (16,22). In our
study, we did not intend to compare the relative degrees of
IC reduction between the upper and lower limbs; however,
we demonstrated the occurrence of dynamic pulmonary
hyperinflation during activities of daily living with the
arms. Furthermore, the movements resemble many unsup-
ported upper-limb exercises that are commonly used during
pulmonary rehabilitation sessions for COPD patients.
Our study revealed a strong correlation between both IC
and Borg dyspnea and peak exercise. Similarly, Marin et al.
(10) demonstrated that pulmonary hyperinflation leads to a
greater degree of dyspnea, fatigue, and physical capacity
limitations. The sensation of dyspnea has been widely
reported in COPD patients during activities of daily living
(23), physical exercises (24-26) and even breathing exercises
(27). However, none of these authors demonstrated an
association between dyspnea and dynamic pulmonary
hyperinflation in COPD patients when performing daily
activities.
Dynamic hyperinflation occurred due to an acute lung
adaptation to hyperpnea and enhanced metabolic require-
ments. Once this overwhelmed stimulus was interrupted
(i.e., during post-activity rest), the respiratory pattern
returned to baseline, and the inspiratory capacity increased.
Many studies in the literature exist regarding the reversibility
of dynamic hyperinflation with the use of bronchodilators
(15,21,28). However, no data have yet been reported
regarding the spontaneous reversibility of dynamic hyperin-
flation. Nevertheless, the tests that we have conducted in our
laboratory confirm that dynamic hyperinflation is sponta-
neously reversible and that it may require up to 10 minutes
for the inspiratory capacity to increase to its baseline value
after the end of the exercise period (15,16).
The Borg scale was also used to measure lower-limb
fatigue during these activities. For all activities, the
perception of fatigue was greater than the sensation of
dyspnea. We did not assess muscle alterations in our
patients, as this was not our goal; however, due to the
systemic characteristics of COPD, we can assume that there
is a reason for this difference that is associated with skeletal
muscle characteristics (29,30). It is likely that the skeletal
muscle alterations triggered early metabolic acidosis, which
may have led to greater perceptions of fatigue reported by
our patients. COPD is a systemic disease that also affects the
musculoskeletal system, decreasing muscle mass due to
disuse and leading to the development of many bioenergetic
abnormalities (9). Maltais et al. (29) reported a reduction in
thigh muscle mass in COPD patients and found that this
group of patients had higher lower-limb fatigue than
sensations of dyspnea during physical activity, possibly
due to physical deconditioning. Many authors have
reported changes in muscle mass (31,32) and bioenergetics,
such as that related to severe myopathy (33), favoring early
skeletal muscle fatigue in COPD patients.
Our patients were not hypoxemic at rest; after performing
all of the activities in this study, SpO2 remained above 80%.
Other studies (31,33) were conducted with patients who
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were not hypoxemic at rest, and they remained within
normal SpO2 levels during exercise. Ramı´rez-Venegas et al.
(34) did not identify any strong associations between either
SpO2 or Borg dyspnea and the 12-minute walking test (r =
-0.45, p,0.05). In our study, we found only a weak
association between these variables (r = -0.28, p= 0.04),
and there were no clinical differences between either SpO2
or Borg dyspnea and the activities of daily living performed.
Despite the fact that the exercise type is strictly different
between the two parameters, SpO2 and Borg dyspnea
behaved similarly in both studies. This suggests that the
sensation of dyspnea is multifactorial and has a low
association with hemoglobin oxygen uptake. It is likely that
vascular outflow and pulmonary perfusion are crucial for
the development of these changes (35,36).
A possible limitation of our study is the fact that we did
not measure the static lung volume of our patients as
residual volume and total lung capacity. This might have
revealed additional data regarding lung function status for
our patients. However, our focus was to evaluate dynamic
changes in lung volume, and the method used was
appropriate to address the problem. As this is one of the
first studies to compare dynamic lung hyperinflation in
patients performing activities of daily living, it is difficult to
compare our results with those from other studies.
However, these findings have an important impact on the
pulmonary rehabilitation of COPD patients in clinical
practice. Based on our results, we can infer that the activities
of daily living should be assessed in these patients, and
patients should be guided by a comprehensive multi-
disciplinary team to provide them with better guidance.
We conclude that during activities of daily living, COPD
patients develop dynamic pulmonary hyperinflation, increased
dyspnea and lower-limb fatigue, which are the main causes of
physical limitations.
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